1. Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1. Issue 10 (2nd March 2012) Authors: Serfaty, Lawrence; Forns, Xavier; Goeser, Tobias; Ferenci, Peter; Nevens, Frederik; Carosi, Giampiero; Drenth, Joost P; Lonjon-Domanec, Isabelle; DeMasi, Ralph; Picchio, Gaston; Beumont, Maria; Marcellin, Patrick Journal: Gut Issue: Volume 61:Issue 10(2012) Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. JNJ‐4178 (AL‐335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus‐Infected Patients Without Cirrhosis: OMEGA‐1. Issue 6 (14th March 2019) Authors: Zeuzem, Stefan; Bourgeois, Stefan; Greenbloom, Susan; Buti, Maria; Aghemo, Alessio; Lampertico, Pietro; Janczewska, Ewa; Lim, Seng Gee; Moreno, Christophe; Buggisch, Peter; Tam, Edward; Corbett, Chris; Willems, Wouter; Vijgen, Leen; Fevery, Bart; Ouwerkerk‐Mahadevan, Sivi; Ackaert, Oliver; Beumon... Journal: Hepatology Issue: Volume 69:Issue 6(2019) Page Start: 2349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Liver safety assessment in clinical trials of new agents for chronic hepatitis B. Issue 2 (11th December 2019) Authors: Fontana, Robert J.; Avigan, Mark I.; Janssen, Harry L. A.; Regev, Arie; Mishra, Poonam; Gaggar, Anuj; Brown, Nathaniel; Wat, Cynthia; Mendez, Patricia; Anderson, Ryan T.; Given, Bruce; Miller, Veronica; Beumont, Maria Journal: Journal of viral hepatitis Issue: Volume 27:Issue 2(2020) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Review of Drug Interactions with Telaprevir and Antiretrovirals. Issue 4 (May 2013) Authors: Van Heeswijk, Rolf PG; Beumont, Maria; Kauffman, Robert S; Garg, Varun Journal: Antiviral therapy Issue: Volume 18:Issue 4(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Issue 2 (22nd February 2020) Authors: Lawitz, Eric; Poordad, Fred; Gutierrez, Julio A.; Beumont, Maria; Beets, Greet; Vandevoorde, Ann; Remoortere, Pieter Van; Luo, Donghan; Vijgen, Leen; Eygen, Veerle Van; Gamil, Mohamed Journal: Health science reports Issue: Volume 3:Issue 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Systematic review with meta‐analysis: hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy. Issue 3 (25th May 2020) Authors: Slaets, Leen; De Ridder, Filip; Lenz, Oliver; Beumont, Maria; Meyvisch, Paul; Verbinnen, Thierry Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗